Stopping GLP-1 Drugs May Increase Heart Attack and Stroke Risk, Study Finds

A study from Cleveland Clinic has added a sobering dimension to the GLP-1 medication story: for the millions who have come to rely on drugs like Ozempic, stopping may carry cardiovascular consequences that rival the conditions the drugs were meant to prevent. As these medications have woven themselves into the fabric of modern chronic disease management, the question of what happens when someone steps away — by necessity or by choice — has moved from theoretical to urgent. The research reminds us that in medicine, as in much of life, the benefits we build can be quietly undone by the act of le